AstraZeneca's Seroquel gets EU approval for bipolar recurrence - Pharmaceutical and Biotechnology News - Pharma Letter
Links shared publicly online about this topic.
- 1,711total visits
AstraZeneca's Seroquel gets EU approval for bipolar recurrence - Pharmaceutical and Biotechnology News - Pharma Letter
AstraZeneca says that its once-daily Serooquel XR (quetiapine fumarate extended-release tablets) and Seroquel have been approved under the European Mutual Recognition Procedure for the prevention of recurrence of bipolar disorder in patients whose manic,
View full resource at thepharmaletter.com
Tags: Bipolar Disorder Medication, Depression, Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, Pharma, Seroquel, AstraZeneca
Most Recently Shared on September 30, 2009 at 3:05 pm By:
RT @ThePharmaLetter: AstraZeneca’s Seroquel gets EU approval for bipolar recurrence http://bit.ly/3cCKZ0 #pharma #depression #bipolar
Advertisement
